Application of PDCA cycle management on the rational use of benzodiazepines in dementia patients with sleep disorders

MU Yonggang; NA Wanqiu; CHEN Ke; PAN Xingen; CHEN Xiaoyun; ZHI Shengli; CHEN Zheli

doi:10.3969/j.issn.2096-5516.2021.01.004

PDF(528 KB)

Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2021, Vol. 4 ›› Issue (1) : 28-32. DOI: 10.3969/j.issn.2096-5516.2021.01.004

Original article

Application of PDCA cycle management on the rational use of benzodiazepines in dementia patients with sleep disorders

Author information +

History +

Abstract

Objective:

To evaluate the effect of PDCA cycle management to improve the rational use of benzodiazepines for dementia patients with sleep disorders.

Method:

In November 2018, the quality assessment group was set up and analyzed the situation of benzodiazepines for dementia patients with sleep disorders during the last four months. The use of benzodiazepines was managed using PDCA cycle from December 2018 to January 2020. The rate of assessment in sleep, rational use of benzodiazepines and incidence rate of adverse effects were compared before and after implementation of PDCA cycle.

Results:

After 4 to 7 PDCA cycles, the evaluation rate of sleep disorders in patients with dementia increased from 7.1% to 98.0%(P < 0.01), and the rational use of benzodiazepines in dementia with sleep disorders increased from 44.7% to 99.0%(P < 0.01). The total adverse effects rate dropped significantly(P < 0.05).

Conclusion:

The PDCA cycle can effectively promote the rational use of benzodiazepines in dementia with sleep disorders, which is worth popularizing in clinical practice.

Key words

PDCA cycle / dementia / sleep disorder / benzodiazepine

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

MU Yonggang , NA Wanqiu , CHEN Ke , et al . Application of PDCA cycle management on the rational use of benzodiazepines in dementia patients with sleep disorders[J]. Chinese Journal of Alzheimer's Disease and Related Disorders. 2021, 4(1): 28-32 https://doi.org/10.3969/j.issn.2096-5516.2021.01.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Longhe Z. 2020 Alzheimer's disease facts and figures[J]. Alzhmer's and Dementia, 2020, 16(3). Cited in this article [1]

[2]	Kinnunen KM, Vikhanova A, Livingston G, et al. The management of sleep disorders in dementia: an update[J]. Curr Opin Psychiatry, 2017, 30(6): 491-497. Cited in this article [1]

[3]	Cheung JM, Bartlett DJ, Armour CL, et al. People with insomnia: experiences with sedative hypnotics and risk perception[J]. Health Expect, 2016, 19(4): 935-947. Cited in this article [1]

[4]	贾建平. 中国痴呆与认知障碍诊疗指南[M]. 北京: 人民卫生出版社, 2016: 27-36. Cited in this article [2]

[5]	陆林. 沈渔邨精神病学[M]. 第6版. 北京: 人民卫生出版社, 2018. Cited in this article [1]

[6]	Jerrah K. Sleep in Alzheimer's Disease-Beyond Amyloid[J]. Neurobiology of Sleep & Circadian Rhythms, 2017, 2:4-14. Cited in this article [1]

[7]	朱荣彦, 郭鹏, 张巍, 等. 阿尔茨海默病与睡眠障碍[J]. 中华老年医学杂志, 2017, 36(1): 1-4. Cited in this article [1]

[8]	Jones RW, Lebrec J, Kahle-Wrobleski K, et al. Disease progression in mild dementia due to alzheimer disease in an 18-Month observational study (GERAS): the impact on costs and caregiver outcomes[J]. Dement Geriatr Cogn Dis Extra, 2017, 7(1): 87-100. Cited in this article [1]

[9]	Frohnhofen H, Netzer N. [Sleep disorders in the elderly : Importance in geriatrics][J]. Z Gerontol Geriatr, 2017, 50(8): 702-705. Cited in this article [1]

[10]	Kazui H, Adachi H, Kanemoto H, et al. Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy[J]. Psychiatry Res, 2017, 251: 312-318. Cited in this article [1]

[11]	章瑜, 谢健. 美金刚对阿尔茨海默病患者精神行为症状和睡眠结构的影响[J]. 浙江医学, 2018, 40(11): 1175-1178. Cited in this article [1]

[12]	Gray SL, Dublin S, Yu O, et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study[J]. BMJ, 2016, 352: i90. Cited in this article [1]

[13]	Verdoux HL, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia?a literature review of epidemiological studies[J]. Psychol Med, 2005, 35(3): 307-315. Cited in this article [1]

[14]	Wu CS, Wang SC, Chang IS, et al. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data[J]. Am J Geriatr Psychiatry, 2009, 17(7):614-620. Cited in this article [1]

[15]	Hansson O, Zetterberg H, Buchhave P, et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study[J]. Lancet Neurol, 2006, 5(3): 228-234. Cited in this article [1]

[16]

Guarnieri

, Caffarra

. Recommendations of the sleep study group of the Italian dementia research association SINDemon clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia:a clinical review[J]. Neurological Sciences, 2014, 35(9): 1329-1348.

Cited in this article [1]

[17]	王玉平, 汪凯, 潘集阳, 等. 中国成人失眠伴抑郁焦虑诊治专家共识[J]. 中华神经科杂志, 2020, (8): 564-574. Cited in this article [1]

[18]	Lundkvist R, Meiling JH, Sandberg M, et al. A proactive plan-do-check-act approach to defect management based on a Swedish construction project[J]. Construction Management & Economics, 2014, 32(11): 1051-1065. Cited in this article [1]

[19]	Nicolay CP, Greenhalgh A. Systematic review of the application of quality improvement methodologies from the manufacturing industry to surgical healthcare[J]. Bri J Surg, 2012, 99(3): 324-335. Cited in this article [1]

[20]	Cousson PY, Decerle N, Munoz-Sanchez ML, et al. The "plan" phase of a Deming cycle:Measurement of quality and outcome of root canal treatments in a university hospital[J]. Eur J Dent Educ, 2019, 23(1): e1-e11. Cited in this article [1]